Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical formulation for external use. It helps prevent local clot formation and reduces swelling in superficial thrombophlebitis, bruises, and related vascular conditions in adult patients.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lioton is a topical antithrombotic used to manage conditions involving superficial clot formation and vascular inflammation.

- Superficial thrombophlebitis: reduces clot propagation and eases pain. - Bruising and contusions: limits hematoma expansion and promotes resolution. - Post‑operative edema: decreases swelling and supports local circulation. - Varicose vein discomfort: alleviates inflammation and discomfort.

Topical heparin may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation: redness or mild itching at the application site. - Erythema: localized redness. - Minor bruising: increased susceptibility to superficial bleeding. - Dryness or peeling of skin.

Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling, or anaphylaxis. - Extensive bleeding: unexpected hemorrhage at or beyond the site. - Heparin‑induced thrombocytopenia: marked drop in platelet count. - Necrosis of skin tissue at application area.

When using Lioton, consider the following safety measures.

- Bleeding risk assessment: evaluate patient history for coagulopathies. - Open wounds: avoid application on broken skin or active infections. - Concurrent anticoagulants: do not combine with systemic anticoagulants without medical supervision. - Skin monitoring: discontinue if severe irritation or allergic signs develop. - Storage: Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Heparin Sodium can interact with other agents affecting coagulation.

Major Interactions (Avoid): - Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants): increased bleeding risk. - Thrombolytic therapy (e.g., alteplase): additive anticoagulant effect. - Antiplatelet drugs (e.g., clopidogrel, aspirin): heightened hemorrhagic potential.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may exacerbate bruising. - Corticosteroid creams: could alter skin absorption. - Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic): monitor for bleeding signs.